Arizona Oncology Associates, East Valley Cancer Center — Tempe, Arizona

Arizona Oncology Associates, East Valley Cancer Center is a clinical research site located in Tempe, Arizona, United States 85284.

Crixeo Clinical Trials Trust Score: 6/100 (FAILING). This profile has not yet been claimed by the site owner.

Arizona Oncology Associates, East Valley Cancer Center has participated in 2 clinical trials.

Therapeutic areas: Acute Myeloid Leukemia, Non-Small Cell Lung Cancer, Urothelial Cancer.

Sponsors: Helsinn Healthcare SA, Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tempe

Browse all research sites in Arizona · View every site in Tempe

Sponsor Feasibility Report

Trust Score: 6/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Arizona Oncology Associates, East Valley Cancer Center?

Arizona Oncology Associates, East Valley Cancer Center has a Crixeo Trust Score of 6/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Arizona Oncology Associates, East Valley Cancer Center conducted?

Arizona Oncology Associates, East Valley Cancer Center has 2 clinical trials on record. Their work covers Acute Myeloid Leukemia, Non-Small Cell Lung Cancer, Urothelial Cancer.

Is Arizona Oncology Associates, East Valley Cancer Center accredited by Crixeo Clinical Trials?

Arizona Oncology Associates, East Valley Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Arizona Oncology Associates, East Valley Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.